Cite
Mangel J, Buckstein R, Imrie K, et al. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Semin Oncol. 2002;29(1):56-69doi: 10.1053/sonc.2002.30143.
Mangel, J., Buckstein, R., Imrie, K., Spaner, D., Crump, M., Tompkins, K., Reis, M., Perez-Ordonez, B., Deodhare, S., Romans, R., Pennell, N., Robinson, J. B., Hewitt, K., Richardson, P., Lima, A., Pavlin, P., & Berinstein, N. L. (2002). Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Seminars in oncology, 29(1), 56-69. https://doi.org/10.1053/sonc.2002.30143
Mangel, Joy, et al. "Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma." Seminars in oncology vol. 29,1 (2002): 56-69. doi: https://doi.org/10.1053/sonc.2002.30143
Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Semin Oncol. 2002 Feb;29(1):56-69. doi: 10.1053/sonc.2002.30143. PMID: 28140093.
Copy
Download .nbib